A Kinder Side of Red Tides?
Investigators conducting a decade-long study into how Florida's "red tide" algal blooms affect human health have discovered several compounds that counteract the toxins produced by the red tide dinoflagellate, Karenia brevis. In an intriguing twist, they are now developing one of these compounds, brevenal, as a potential treatment for cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). In cellular and animal models brevenal appears far more potent than existing drugs for CF and COPD and exhibits the unique quality of both suppressing inflammation and boosting mucociliary clearance.
Download Publication (Adobe .pdf format)